Brief: Shenzhen Hepalink Pharmaceutical Group Proposes To Expand Business Scope
26/08/2021 16:31
Aug 26 (Reuters) - Shenzhen Hepalink Pharmaceutical Group Co
Ltd 002399.SZ :
* PROPOSES TO EXPAND BUSINESS SCOPE TO INCLUDE
NON-RESIDENTIAL
PROPERTY LEASING & RESIDENTIAL PROPERTY LEASING
Source text for Eikon: ID:nHKS4f8kGc
Further company coverage: 002399.SZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shenzhen Hepalink Pharmaceutical Co
See all newsBrief: Shenzhen Hepalink Pharmaceutical Group Says Enoxaparin Sodium Injection Obtains New Manufacturer Authorization From EMA
Brief: Shenzhen Hepalink Pharmaceutical Group Posts QTRLY Net Profit Attributable Of RMB156.6 Million
Brief: Shenzhen Hepalink Pharmaceutical Posts Profit Attributable RMB646.7 Million For Year
Brief: Shenzhen Hepalink Pharmaceutical Says Enoparin Approved In Argentina
Brief: Shenzhen Hepalink Pharmaceutical Says H1710 Injection Received Approval For From NMPA